Neonatal & Pediatric ICU

Berlin Heart Inc. is a US-based medical device manufacturer specializing in ventricular assist devices (VADs) for mechanical circulatory support in pediatric and adult populations. Founded in 2005 as the North American subsidiary of Berlin Heart GmbH, the company develops and markets innovative extracorporeal circulatory support systems designed to bridge pediatric and neonatal patients awaiting heart transplantation or to support recovery from acute heart failure. The flagship EXCOR® Pediatric system has demonstrated clinical reliability with use in over 2,300 pediatric patients worldwide and is FDA-approved for use across US implanting centers. Berlin Heart maintains strategic partnerships with leading cardiac centers throughout North America and provides comprehensive clinical support services including anticoagulation management, training, and outcomes documentation through the ACTION Network collaborative initiative.

Kentec Medical, established in 1970, is a trusted medical device and supplies manufacturer serving hospitals and healthcare systems across the United States. The company specializes in innovative solutions for blood management, enteral feeding, neonatal care, pharmacy dispensing, and general medical consumables under its proprietary Ameritus™ brand. Key product lines include the SAMMI® closed blood draw and flush sets for safe infusion management, HUMMI® micro-draw blood devices designed to reduce complications in peripheral arterial blood draws, ISOFit™ EN 80369-3 compliant enteral feeding systems, HAVE A HEART® neonatal electrodes, and specialized pharmacy dispensers. Kentec Medical combines clinical expertise with patient-centered design to deliver products that improve outcomes while reducing healthcare costs. The company maintains a strong commitment to clinical education and evidence-based practices, particularly in neonatal intensive care, vascular access, and nutritional support.

CHS USA Incorporated is a national manufacturer and distributor of medical and neonatal supplies serving hospitals and outpatient surgery centers. The company specializes in high-quality hospital specialty products including neonatal care solutions, pediatric monitoring devices, vascular access products, tubing and extension sets, and medical-grade consumables. CHS USA manufactures proprietary brands such as mamaRoo baby swings, Olympic Circumstraint systems, infant stabilization boards, and MISI syringes for diagnostic imaging. The company emphasizes safety, reliability, and industry-standard compliance across all product lines, supported by expert service teams and personalized customer support.

NovaMedUSA, Inc. is a manufacturer and distributor of specialty medical products serving anesthesiology, cardiology, neonatology, and critical care markets. The company specializes in temperature monitoring solutions, including core body temperature probes, neonatal skin temperature sensors compatible with major incubator systems (GE/Ohmeda, Dräger, Atom Medical), and wireless temperature monitoring. Product lines include fiber optic laryngoscopes (PREMIER, standard, LED, and MRI-conditional variants) for intubation procedures, esophageal stethoscopes (LIFESOUND) for heart/breath sound monitoring, and conductive patient warming systems (KOALA for adults and KOALA Infant Warmer for neonates) designed to prevent perioperative hypothermia. NovaMedUSA emphasizes energy-efficient, eco-friendly technology and SCIP-INF-10 compliant products. The company operates customer support Monday–Friday, 8:30 am–8:30 pm EST, with dedicated channels for current customers, prospective buyers, and dealer partners.

Kol Bio-Medical Instruments, Inc. is a medical device sales and distribution company specializing in direct sales representation, supply chain management, and go-to-market strategies for medical device manufacturers. The company operates as a strategic partner to device makers, providing clinically-oriented sales teams, market access, product revitalization services, and end-to-end warehousing and distribution capabilities. The company serves multiple hospital departments and procedural areas including interventional cardiology and radiology labs, operating rooms, critical care units, cardiac surgery programs, trauma centers, and neonatal intensive care units (NICU). Their expertise spans diagnostic and therapeutic devices used in acute care settings, life-support technologies, and specialized surgical equipment. Kol Bio-Medical combines direct sales representation with supply chain logistics, offering complete go-to-market planning, clinical education, inventory management, order fulfillment, and product tracking. The company employs representatives with clinical expertise who can educate healthcare providers on device applications and customer-level technical concepts. Core service offerings include growth strategy development, product line revitalization for mature devices, and comprehensive distribution from their Sterling, Virginia warehouse facility. The company does not manufacture devices but rather functions as a trusted distributor and sales partner for third-party medical device manufacturers seeking to expand market presence and revenue in hospital and acute care settings.

Marian Medical, Inc. is a specialized manufacturer and distributor of neonatal and pediatric medical devices serving hospitals, clinics, institutional healthcare providers, and home care patients. With over 15 years of neonatal manufacturing experience, the company produces FDA-cleared devices including neonatal PICC lines, feeding tubes, extension sets, urinary drainage catheters, procedure trays, blood administration sets, reusable syringes, and stoma care accessories. Operating two divisions—MarianMedicalOnline.com for institutional bulk purchasing and MarianMedicalHomeCare.com for retail direct-to-consumer—the company serves the neonatal nursing community with high-quality products and educational programs designed to enhance clinician skill levels, improve patient outcomes, and strengthen patient safety standards.

NeoChild, LLC is a neonatal and pediatric medical device manufacturer specializing in safety-focused enteral feeding systems, IV therapy products, and urinary drainage systems. The company develops and manufactures patented safety products designed to prevent misconnections and improve patient outcomes in neonatal intensive care units. Product portfolio includes enteral feeding tubes, enteral syringes, IV extension sets, urinary catheters, and customizable convenience kits. NeoChild has vertically integrated manufacturing operations on-shore to ensure supply chain reliability and sterility assurance, particularly following pandemic-related supply disruptions. The company is led by senior management with over 40 years of combined neonatal and intravenous therapy experience. NeoChild maintains certifications as a diversity supplier and emphasizes cost-effective solutions for hospital systems and neonatal care providers. All products are manufactured with attention to safety protocols and clinical requirements specific to vulnerable neonatal and pediatric populations.

Navi Medical Technologies is an Australian medtech company founded in 2017, specializing in innovative pediatric medical devices for critically ill newborns and children. The company addresses a critical gap in the market, as only 5% of FDA-approved devices are suitable for neonates. Navi's flagship product, the Neonav® ECG Tip Location System, uses real-time ECG surveillance technology and proprietary algorithms to enable non-invasive bedside verification of Central Vascular Access Device (CVAD) tip location in neonatal and pediatric patients. This addresses the high prevalence of CVAD malposition (>40% of umbilical venous catheters and 37% of peripherally inserted central catheters at insertion) and migration (up to 36% of UVCs and 28% of neonatal PICCs), which can lead to serious complications including cardiac arrhythmias, vessel damage, hepatic extravasation, and cardiac tamponade. The Neonav has received FDA 510(k) clearance and is supported by two patents. The company has secured $4.3 million in funding and collaborates closely with clinicians in neonatal and pediatric intensive care units to develop clinically relevant solutions.